Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Small

Showing results (241-250 of 361) with videos related to

Pageof 37
Sort By:
Prostate Cancer and Prostatic Diseases|August 24, 2023
Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamideYaoYao Pollock, Matthew R Smith, Fred Saad, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
European Urology|March 19, 2017
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Matthew R Smith, Fred Saad, Dana E Rathkopf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Clinical Genitourinary Cancer|February 14, 2009
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical researchMichael J Morris, Ethan M Basch, George Wilding, et al.
Pageof 37

Showing results (241-250 of 361) with videos related to

Sort By:
Pageof 37
Prostate Cancer and Prostatic Diseases|August 24, 2023
Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamideYaoYao Pollock, Matthew R Smith, Fred Saad, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer TypesWilliam S Chen, Mohammed Alshalalfa, Shuang G Zhao, et al.
Cancer Research|July 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor ProgressionRaunak Shrestha, Lisa N Chesner, Meng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancerMatthew R Smith, Fairooz Kabbinavar, Fred Saad, et al.
JCI Insight|September 7, 2018
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancerYang Su, Yue Liu, Christopher R Behrens, et al.
European Urology|March 19, 2017
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Matthew R Smith, Fred Saad, Dana E Rathkopf, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Clinical Genitourinary Cancer|February 14, 2009
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical researchMichael J Morris, Ethan M Basch, George Wilding, et al.
Pageof 37